Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 19;59(4):e00239-21.
doi: 10.1128/JCM.00239-21. Print 2021 Mar 19.

Point-Counterpoint: Should Clinical Microbiology Laboratories Report Vancomycin MICs?

Sara L Revolinski  1 , Christopher D Doern  2
Affiliations

Point-Counterpoint: Should Clinical Microbiology Laboratories Report Vancomycin MICs?

Sara L Revolinski et al. J Clin Microbiol. .

Abstract

INTRODUCTIONWith numerous reported challenges to reporting MICs for vancomycin, clinical laboratories are attempting to identify accurate methods for MIC testing. However, the issues of poor reproducibility, accuracy, and clinical utility remain a challenge. In this Point-Counterpoint, Dr. Sara Revolinski discusses the pros of reporting MICs for vancomycin, while Dr. Christopher Doern argues for the use of caution.

PubMed Disclaimer

References

    1. Rybak M, Lomaestro B, Rotschafer JC, Moellering R, Craig W, Billeter M, Dalovisio JR, Levine DP. 2009. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 66:82–98. doi:10.2146/ajhp080434. - DOI - PubMed
    1. Moellering RC. 2006. Vancomycin: a 50-year reassessment. Clin Infect Dis 42(Suppl 1):S3–S4. doi:10.1086/491708. - DOI - PubMed
    1. Claeys KC, Zasowski EJ, Casapao AM, Lagnf AM, Nagel JL, Nguyen CT, Hallesy JA, Compton MT, Kaye KS, Levine DP, Davis SL, Rybak MJ. 2016. Daptomycin improves outcomes regardless of vancomycin MIC in a propensity-matched analysis of methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother 60:5841–5848. doi:10.1128/AAC.00227-16. - DOI - PMC - PubMed
    1. Neely MN, Kato L, Youn G, Kraler L, Bayard D, van Guilder M, Schumitzky A, Yamada W, Jones B, Minejima E. 2017. Prospective trial on the use of trough concentration versus area under the curve to determine therapeutic vancomycin dosing. Antimicrob Agents Chemother 62:e02042-17. doi:10.1128/AAC.02042-17. - DOI - PMC - PubMed
    1. Meng L, Wong T, Huang S, Mui E, Nguyen V, Espinosa G, Desai J, Holubar M, Deresinski S. 2019. Conversion from vancomycin trough concentration-guided dosing to area under the curve-guided dosing using two sample measurements in adults: implementation at an academic medical center. Pharmacotherapy 39:433–442. doi:10.1002/phar.2234. - DOI - PubMed

MeSH terms

LinkOut - more resources